Translating Aging
by BioAge Labs
Latest episode
A Promise Kept — Phase 1 Data for a 7-KC-Clearing Drug (Oki…
A Promise Kept — Phase 1 Data for a 7-KC-Clearing Drug (Oki…
About this podcast
On Translating Aging, we talk with the worldwide community of researchers, entrepreneurs, and investors who are moving longevity science from the lab to the clinic. We bring you a commanding view of the entire field, in the words of the people and companies who are moving it forward today. The podcast is sponsored by BioAge labs, a clinical-stage biotechnology company developing therapies to extend human healthspan by targeting the molecular causes of aging.
Episodes
The newest 20 of 63 episodes
- A Promise Kept — Phase 1 Data for a 7-KC-Clearing Drug (Oki O'Connor, Cyclarity Tx) · 40 min · Episode 62Matthew "Oki" O'Connor is the CEO of Scientific Affairs at Cyclarity Therapeutics, a clinical-stage biotech building a new class of medicines designed not to slow the…
- Beyond senolytics: senoadaptive drugs & clinical data on GPX4 modulation (Dr. Marco Quarta, Rubedo) · 47 min · Episode 61Marco Quarta is co-founder and Chief Scientific Officer of Rubedo Life Sciences, a precision-therapeutics company developing medicines that target the pathological cell states…
- Investing in the Future of Longevity (Sergey Jakimov, Managing Partner, LongeVC) · 51 min · Episode 60Sergey Jakimov is the Managing Partner and co-founder of LongeVC, one of Europe's most active longevity-focused venture capital firms, currently raising its second fund targeting…
- Molecules to medicine: The translational landscape of aging interventions (Panel discussion at BAAM 2025) · 48 min · Episode 59In this special episode, host Chris Patil (VP-Media, BioAge) moderates a live panel discussion at the 25th Bay Area Aging Meeting at UCSF, bringing together six leading voices…
- Partial epigenetic reprogramming: the "holy grail" for aging therapeutics (Michael Ringel, Life Biosciences) · 38 min · Episode 58Michael Ringel is the Chief Operating Officer of Life Biosciences, a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of…
- Cell Reset Therapeutics to Extend Healthspan and Lifespan (Janine Sengstack, Junevity) · 37 min · Episode 57Dr. Janine Sengstack is the Chief Scientific Officer and co-founder of Junevity, a company created in 2023 with the mission of extending health span and lifespan through what…
- Building the Infrastructure for Longevity Medicine: ARPA-H's PROSPR Program (Dr. Andrew Brack, Program Manager) · 40 min · Episode 56Dr. Andrew Brack, Program Manager at the Advanced Research Projects Agency for Health (ARPA-H), discusses PROSPR (Proactive Solutions for Prolonging Resilience), an ambitious new…
- Decoding Stem Cell Rejuvenation Factors (Markus Gstöttner, CEO of Clock.bio) · 27 min · Episode 55Markus Gstöttner is the CEO of Clock.bio, a company devoted to extending and improving the quality of life by reversing the harmful effects of time in our cells. In this episode…
- Eliminating Pathogenic Cells to Treat Disease (Adam Freund & Remi Laberge, Arda Therapeutics) · 46 min · Episode 54Adam Freund (CEO) and Remi Laberge (CTO) are the founders of Arda Therapeutics, a biotechnology company developing novel therapies that selectively eliminate harmful cell…
- Precision Epigenetic Medicines to Extend Healthspan (Alex Aravanis, Moonwalk Biosciences) · 42 min · Episode 53Alex Aravanis is the CEO and co-founder of Moonwalk Biosciences, a biotechnology company pioneering precision epigenetic medicines. In this episode, Chris and Alex discuss…
- Hevolution: Extending Global Healthspan (Dr. Mehmood Khan, CEO) · 43 min · Episode 52In this episode, Chris Patil speaks with Dr. Mehmood Khan, CEO of Hevolution Foundation, about the organization's mission to extend healthy human lifespan and better understand…
- Harnessing the Secretome to Combat Age-Related Immune Dysfunction (Dr. Hans Keirstead, Immunis) · 48 min · Episode 51Hans Keirstead, PhD, is the Chairman of the Board at Immunis, a biotechnology company researching and developing immune secretome products to address age-driven immune deficits…
- Delaying menopause, extending healthspan: The promise of AMH-based therapeutics (Daisy Robinton, Oviva Therapeutics) · 37 min · Episode 50Dr. Daisy Robinton, co-founder and CEO of Oviva Therapeutics, discusses the company's innovative approach to improving women's healthspan by targeting the biology of ovarian…
- Gene Therapies to Treat and Reverse Aging (Noah Davidsohn, Rejuvenate Bio) · 35 min · Episode 49Dr. Noah Davidsohn, co-founder and CSO of Rejuvenate Bio, discusses the company's innovative work using gene therapies to treat age-related diseases in dogs and humans. In his…
- 30 Years of Aging Biology: A Pioneer's Perspective (Cynthia Kenyon, VP-Aging Research at Calico Labs) · 44 min · Episode 4830 Years of Aging Biology: A Pioneer’s Perspective (Cynthia Kenyon - VP Aging Biology, Calico Labs) Dr. Cynthia Kenyon reflects on the evolution of the longevity field over the…
- XPRIZE Healthspan: Catalyzing Therapies for Aging (Jamie Justice, PhD) · 55 min · Episode 47Dr. Jamie Justice is Executive Director of the newly launched XPRIZE Healthspan, a $101 M international competition to accelerate therapeutics targeting aging biology. In…
- "How We Age: The Science of Longevity" (Professor Coleen Murphy, Princeton) · 37 min · Episode 46Dr. Coleen Murphy is a prominent aging researcher and author of the upcoming book “How We Age: The Science of Longevity” from Princeton University Press. In this wide-ranging…
- From Startup to Acquisition (Nick Hertz, Mitokinin) · 42 min · Episode 45Dr. Nicholas Hertz is the co-founder and former CSO of Mitokinin, a biotech company developing therapies targeting damaged mitochondria in neurodegenerative disease. Mitokinin…
- Catalyzing moonshots in longevity biotech (Alex Colville, Age1) · 41 min · Episode 44Dr. Alex Colville is the co-founder and General Partner of Age1 Ventures, a recently launched VC firm focused on funding contrarian, founder-led biotech companies aiming to…
- Reversing Skin Aging at the Cellular Level (Carolina Reis Oliveira and Alessandra Zonari, OneSkin) · 36 min · Episode 43Dr. Carolina Reis Oliveira and Dr. Alessandra Zonari are the co-founders of OneSkin, a company developing science-backed skincare products to reverse skin aging at the cellular…
